| GTO ID | GTC0918 |
| Trial ID | ChiCTR2100043305 |
| Disease | Hematologic Cancer |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | A clinical study on the therapeutic safety, tolerability, efficacy and pharmacokinetic characteristics of chimeric antigen receptor T cells in patients with hematological malignancies |
| Year | 2021 |
| Country | China |
| Company sponsor | Shanghai Zhaxin Integrated Traditional Chinese and Western Medicine Hospital |
| Cohort 1 | |||||||
|
|||||||